Clinical evaluation of a new antihistaminic agent--Tavergyl
Beritić, T.
Lijecnicki Vjesnik 83(9): 1065-1070
1971
ISSN/ISBN: 0024-3477 PMID: 4403703 Document Number: 40197
Document emailed within 1 workday
Related Documents
Bindslev-Jensen, C.; Frølund, L.; Svendsen, U.G. 1989: Cetirizine. a new non-sedative antihistaminic agent Ugeskrift for Laeger 151(16): 1011-1012Shaĭdrov, V.V.; Ionov, I.D. 1988: Evaluation of the immunotoxicity of sulfanilamide, anti-inflammatory and antihistaminic preparations Farmakologiia i Toksikologiia 51(3): 82-84
Stowater, J.L.; Kneller, S.K. 1979: Clinical evaluation of metrizamide as a myelographic agent in the dog Journal of the American Veterinary Medical Association 175(2): 191-195
Tanga, M.R.; Antani, J.A.; Kabade, S.S. 1975: Clinical evaluation of metronidazole as an anti-inflammatory agent International Surgery 60(2): 75-76
Doongaji, D.R.; Sheth, A.S.; Paul, T.; Parikh, R.M.; Vahora, S.A.; Apte, J.S.; Desai, N.K.; Upadhaya, A.K.; Satoskar, R.S. 1983: Clinical evaluation of centbutindole as an anti-psychotic agent Indian Journal of Medical Research 78: 126-133
Kramer, R.; Rosendorff, C.; Bloom, D. 1974: Clinical evaluation of indoramin as the sole agent for the treatment of hypertension South African Medical Journal 48(37): 1569-1572
Pretolani, E.; Biagioli, R.; Garaffoni, O. 1977: Clinical evaluation of a quinazoline-derivative hypotensive agent (prazosin or Minipress) Bollettino Della Societa Italiana di Cardiologia 22(9): 1507-1514
Di Veroli, C.; Compagno, S. 1982: Clinical evaluation of a beta-blocking agent in a single daily dose La Clinica Terapeutica 101(6): 623-628
Salmini, G.; Cione, R.; Oldrini, R. 1970: Clinical evaluation of the therapeutic action of a beta-blocking agent associated with a nitroderivative Minerva Cardioangiologica 18(5): 311-315
Short, C.E.; Miller, R.L. 1978: Comparative evaluation of the anticholinergic agent glycopyrrolate as a preanesthetic agent Veterinary Medicine-Small Animal Clinician 73(10): 1269-1273
Aslanian, V.; Lemaignen, H.; Bunouf, P.; Schiratti, M.; Lambrechts, M.; Lundby, B.; Borseth, A.; Svaland, M. 1995: Clinical evaluation of the tolerability of gadodiamide, a new nonionic contrast agent in MRi of the central nervous system Journal de Radiologie 76(7): 431-434
Glorioso, S.; Romeo, B.; Borsatti, A.; Todesco, S. 1977: Comparative clinical evaluation of the effectiveness and tolerance of a new antihypertensive agent, DL 150 IT, administered alone and in combination with reserpine or propranolol La Clinica Terapeutica 83(3): 279-299
Murata, S.; Kobayashi, A.; Takeuchi, T.; Nakajima, H.; Yoshida, A.; Kurosawa, Y.; Miki, S.; Mizoguchi, T.; Sakurai, T.; Kawatani, A. 1996: Clinical evaluation of the efficacy of an antithrombin agent "Argatroban" combined with exercise therapy on increase of the skeletal muscle blood flow Nihon Geka Hokan. Archiv für Japanische Chirurgie 65(3): 109-119
Novotný, P. 1973: An antihistaminic with antidepressant action Casopis Lekaru Ceskych 112(41): 1276-1277
Dry, J.; Pradalier, A. 1977: Current status of antihistaminic therapy La Revue du Praticien 27(59): 4145-6 4151-4
Römer, D.; Weidmann, H. 1966: Pharmacological studies on the new antihistaminic Tavegil Die Medizinische Welt 51: 2791-2794
Duchene-Marullaz, P.; Rispat, G.; Perriere, J.P. 1971: Several antihistaminic pharmacodynamic aspects, especially of Eprozinol Therapie 26(1): 155-162
Alekhin, E.K.; Krasilova, I.L. 1998: The immunotropic activity of H1 antihistaminic preparations Eksperimental'naia i Klinicheskaia Farmakologiia 61(2): 79-86
Brandt, S. 2013: The clinical effects of zinc as a topical or oral agent on the clinical response and pathophysiologic mechanisms of acne: a systematic review of the literature Journal of Drugs in Dermatology: Jdd 12(5): 542-545
Cheng, H.C.; Woodward, J.K. 1982: A kinetic study of the antihistaminic effect of terfenadine Arzneimittel-Forschung 32(9a): 1160-1166